Total Debt
$42M
Net Debt
-$142.9M
Foghorn Therapeutics Inc. currently has $42M in total debt. Net debt is -$142.9M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
FHTX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.04 | 0.18 | -0.14Net Cash | 0.22 | 18.9% |
| 2025-12-31 | 0.04 | 0.16 | -0.12Net Cash | 0.20 | 20.8% |
| 2025-09-30 | 0.02 | 0.18 | -0.16Net Cash | 0.20 | 11.0% |
| 2025-06-30 | 0.02 | 0.20 | -0.17Net Cash | 0.23 | 10.5% |
| 2025-03-31 | 0.03 | 0.22 | -0.19Net Cash | 0.26 | 13.5% |
| 2024-12-31 | 0.04 | 0.24 | -0.21Net Cash | 0.28 | 13.1% |
| 2024-09-30 | 0.04 | 0.27 | -0.23Net Cash | 0.31 | 12.7% |
| 2024-06-30 | 0.04 | 0.29 | -0.24Net Cash | 0.33 | 12.5% |
| 2024-03-31 | 0.04 | 0.21 | -0.16Net Cash | 0.26 | 16.9% |
| 2023-12-31 | 0.05 | 0.23 | -0.19Net Cash | 0.29 | 15.8% |
| 2023-09-30 | 0.05 | 0.26 | -0.21Net Cash | 0.31 | 15.0% |
| 2023-06-30 | 0.05 | 0.28 | -0.24Net Cash | 0.34 | 14.1% |
| 2023-03-31 | 0.05 | 0.32 | -0.27Net Cash | 0.37 | 13.4% |
| 2022-12-31 | 0.05 | 0.35 | -0.29Net Cash | 0.40 | 12.7% |
| 2022-09-30 | 0.05 | 0.37 | -0.32Net Cash | 0.43 | 12.3% |
| 2022-06-30 | 0.05 | 0.39 | -0.34Net Cash | 0.46 | 12.0% |
| 2022-03-31 | 0.06 | 0.42 | -0.37Net Cash | 0.49 | 11.6% |
| 2021-12-31 | 0.06 | 0.15 | -0.10Net Cash | 0.52 | 11.2% |
| 2021-09-30 | 0.08 | 0.12 | -0.04Net Cash | 0.19 | 43.0% |
| 2021-06-30 | 0.08 | 0.14 | -0.06Net Cash | 0.21 | 39.2% |
| 2021-03-31 | 0.08 | 0.16 | -0.08Net Cash | 0.23 | 35.8% |
| 2020-12-31 | 0.08 | 0.19 | -0.10Net Cash | 0.26 | 32.1% |
| 2020-09-30 | 0.07 | 0.07 | -0.00Net Cash | 0.14 | 49.8% |
| 2020-06-30 | 0.07 | 0.04 | 0.03 | 0.09 | 69.7% |
| 2020-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.00 | — |
| 2019-12-31 | 0.02 | 0.01 | 0.00 | 0.02 | 74.4% |
| 2019-03-31 | 0.00 | 0.04 | -0.04Net Cash | 0.00 | — |